GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 351 - 375 of 4050 in total
Antibody Patient Onset (days) Symptom ▲ GlyTouCan ID Arbitrary Fluorescence Units (AFU)
IgG Patient 2 15 mild
G54064FW
98
IgG Patient 2 15 mild
G57449OF
209
IgG Patient 2 15 mild
G58547FH
41
IgG Patient 2 15 mild
G58969RU
45
IgG Patient 2 15 mild
G60761LT
845
IgG Patient 2 15 mild
G61399NC
105
IgG Patient 2 15 mild
G61751GZ
47
IgG Patient 2 15 mild
G62222PE
297
IgG Patient 2 15 mild
G62826CL
2402
IgG Patient 2 15 mild
G63074CQ
39
IgG Patient 2 15 mild
G64669AQ
3026
IgG Patient 2 15 mild
G65889KE
70
IgG Patient 2 15 mild
G66937TJ
46
IgG Patient 2 15 mild
G67045LB
33
IgG Patient 2 15 mild
G68461PT
164
IgG Patient 2 15 mild
G68703KI
4110
IgG Patient 2 15 mild
G69912LP
19530
IgG Patient 2 15 mild
G71142DF
103
IgG Patient 2 15 mild
G71469XA
263
IgG Patient 2 15 mild
G72424VO
74
IgG Patient 2 15 mild
G72739GY
705
IgG Patient 2 15 mild
G73271MD
72
IgG Patient 2 15 mild
G75896PD
158
IgG Patient 2 15 mild
G76355TG
207
IgG Patient 2 15 mild
G76615YG
30

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024